Hybrid Closed Loops (HCL) for people living with type 1 diabetes
Hybrid closed loop systems (HCLs), also referred to as ‘artificial pancreases’, are devices that include an insulin pump and a continuous glucose monitor (CGM). These devices use technology to automatically monitor and deliver the required amount of insulin simply and with ease. This helps to keep glucose levels within a desirable range for a person living with type 1 diabetes.
Roll-out in Surrey Heartlands - status May 2024
NHS England has issued guidance for the roll-out of Hybrid Closed Loops (HCLs) for people living with type 1 diabetes. As soon as we receive further information, which includes confirmation of which HCL devices will be available through a national framework (and therefore what can be offered across Surrey Heartlands), we will work with health system partners to deliver devices through a phased approach to eligible patients, using a fair and equitable process in line with national guidance from NHS England.
We want to support our patients in having an improved quality of life and increased flexibility in managing their diabetes, and we are committed to following the NICE and NHS England guidance. When we have an update on timelines we will communicate with patients and our health and care partners.
More information about HCLs can be found on the Diabetes UK website: Closed loop systems | Diabetes tech | Diabetes UK.
More information about diabetes is on our Long term conditions page.